NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair, CEO and 10% owner Ron Bentsur bought $53K of Nuvectis Pharma, Inc.
Bought$53,410
$7.63Price
7,000Shares
What NVCT did for a copier
- $1,000 copied at Fri, Mar 18 open, $7.93
- $1,174
- S&P 500, same days
- −5.4%
Measured over 30 trading days, to the May 2 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +54.9% against the S&P 500, and 7 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Mar 17. Filed Fri, Mar 18, 4:31 AM ET, before the open. Returns use the Mar 18 open and the May 2 close. Not investment advice.